Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques

There are numerous reports suggesting that fibroblast activating protein-α (FAP-α) plays an important role in invasion of various tumor types. We studied the expression pattern of FAP-α in esophageal squamous cell carcinoma (ESCC) patients who had not been treated primarily and those who had received neoadjuvant radiochemotherapy. Our goal was to establish whether readily available tissue specimens fixed in formalin and stored in paraffin blocks for years might still be a source of FAP-α RNA for PCR analysis. The study included 20 patients divided into two groups, 10 patients in each group. We evaluated the expression of FAP- α by PCR techniques in fresh frozen and in paraffin-embedded tissues, and compared it to the expression in non-cancer tissues. To detect the protein expression level of FAP-α in paraffin-embedded tissues we used chromogenic immunohistochemical (IHC) staining. Data were analyzed by t-test or the nonparametric Wilcoxon matched pair test using Statistica 12.5 software. We observed an increased level of the FAP-α gene and protein expression in cancer tissues when compared with their corresponding normal tissues. However, statistically significant differences were found only in the group of patients untreated before surgery. RNA extracted from paraffin-embedded tissue sections had very low quality, especially in the context of degradation. FAP-α remains a highly altered participant of a complex microenvironment in esophageal squamous cell carcinoma, and its role in cell signaling requires further study. In this paper, we conclude that the use of a regular RT-PCR method for diagnostic purposes, which we have presented in an earlier paper, can be as good as qRT-PCR. Also, immunohistochemistry proved to be very useful and the only reliable method that can be used on longterm stored formalin-fixed, paraffin-embedded tissues.

[1]  O. De Wever,et al.  Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations , 2016, Molecular oncology.

[2]  Dehai Che,et al.  Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis , 2015, PloS one.

[3]  S. Ha,et al.  The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma , 2014, PloS one.

[4]  A. Sikorski,et al.  Upregulated expression and activation of membrane‑associated proteases in esophageal squamous cell carcinoma. , 2014, Oncology reports.

[5]  J. Lai,et al.  Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs , 2013, FEBS open bio.

[6]  Timothy Marsh,et al.  Fibroblasts as architects of cancer pathogenesis. , 2013, Biochimica et biophysica acta.

[7]  James O. Jones,et al.  Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.

[8]  Kunwei Shen,et al.  Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.

[9]  J. Isaacs,et al.  Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. , 2012, Journal of the National Cancer Institute.

[10]  J. Isaacs,et al.  Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy , 2012, Molecular Cancer Therapeutics.

[11]  Y. Huang,et al.  Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions , 2011, Clinical & Experimental Metastasis.

[12]  M. Gorrell,et al.  Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α , 2011, The FEBS journal.

[13]  S. Hoerstrup,et al.  Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata , 2011, European heart journal.

[14]  Rafael Sirera,et al.  The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  E. Montgomery,et al.  Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers , 2009, Cancer biology & therapy.

[16]  J. Nesland,et al.  Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  B. O'connor,et al.  Seprase: an overview of an important matrix serine protease. , 2008, Biochimica et biophysica acta.

[18]  Silke von Ahlfen,et al.  Determinants of RNA Quality from FFPE Samples , 2007, PloS one.

[19]  P. Bechi,et al.  Real-time PCR Analysis of RNA Extracted From Formalin-fixed and Paraffin-embeded Tissues: Effects of the Fixation on Outcome Reliability , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[20]  Yuling Luo,et al.  Direct quantification of gene expression in homogenates of formalin-fixed, paraffin-embedded tissues. , 2006, BioTechniques.

[21]  E. Puré,et al.  Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. , 2006, Human pathology.

[22]  G. McCaughan,et al.  Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line , 2005, Hepatology.

[23]  Thomas Kelly,et al.  Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[25]  A. Houghton,et al.  FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor , 2004, Oncogene.

[26]  U. Müller-Ladner,et al.  Microarrays demystified. , 2004, Environmental health perspectives.

[27]  Thomas Kelly,et al.  Seprase complexes in cellular invasiveness , 2003, Cancer and Metastasis Reviews.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  J. Park,et al.  Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.

[30]  C. Abbott,et al.  Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis , 1999, Hepatology.

[31]  K. Umeki,et al.  CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma , 1995, International journal of cancer.

[32]  W. T. Chen,et al.  A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.

[33]  Thomas Kelly,et al.  Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. , 2012, International review of cell and molecular biology.

[34]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.

[35]  A. Houghton,et al.  FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. , 2004, Oncogene.

[36]  S. Iwata,et al.  Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. , 2002, Cellular immunology.